Abstract submission guidelines

Abstract Submission

– Abstracts should be submitted online.  Abstracts sent by fax or post shall not be accepted.

– All accepted abstracts will be published in the Journal of KazNMU Asfendiyarov.

– Submission of an abstract implies that the presenting author will register for and attend the conference to present the abstract either as an oral presentation or as a poster.

– Abstracts must be written in English, Russian or Kazakh Languages

– Presentations should be made in English, Russian or Kazakh Languages

– Abstracts must not exceed 450 words in total

– Abstract submission deadline: March 10, 2018

– Notice mail about the abstract acceptance: March 15, 2018


– Please indicate your presentation preference (oral or poster presentation).

– Write abstract title with first Capital letters only (try to avoid abbreviations).

– Please use Times New Roman font. Size 12, Space:1 inch

– In Authors section please state authors’ full names (without any academic titles) & full address of the organization the authors study/work. Other than that, do not insert any institution, researchers or sponsoring program’s details at the abstract text.

– State the author who will present the poster/presentation (*Presenter).

– Abstracts should be written in clear, concise language & authors are requested to carefully check the spelling. Authors are responsible for spelling & accuracy.

– Abstracts not conforming to any of requirements written above shall not be considered, irrespective of their contents.

– Abstracts must not exceed 450 words in total.

– For submissions to be considered, at least one of the abstract’s authors must have completed the congress registration procedure.

Abstract text CAN be divided in following sections. Section should be also written in the abstract text as a section heading:

  • Background / Aim
  • Materials and Methods
  • Results (quantitative and / or statistical data)
  • Discussion
  • Conclusion
  • Key words

Abstracts can be written on any of the following topics, but not limited to them. We look forward to any type of abstract that has correlation with human health sciences.

Main topics/ conference scope

  • Molecular Medicine
  • Medical Genetics
  • Population Genetics
  • Developmental Genetics
  • Biomarkers/Diagnostics
  • Cancer and Other Diseases
  • Characterisation of Cellular Vesicles
  • microRNAs and Proteins in Exosomes
  • Therapeutic Applications
  • Application of DNA sequencing
  • Data Analysis and Bioinformatics
  • Disease related biomarkers
  • Personalized Medicine
  • Pharmacogenomics
  • Epigenomics
  • State of art technologies (CRISPR Cas 9, NGS, single cell live imaging, etc)
  • Advances in Prenatal screening techniques
  • Genetics screening
  • Stem cell and regeneration
  • Nuclear medicine and molecular imaging
  • Cell and gene therapy
  • Diagnostic genetic testing
  • Medical and molecular diagnosis
  • Nanomedicine


Other than research abstracts, you MAY also write an abstract of literature review of any topic. Here is a sample review abstract:


Sample Abstract (for literature review)

Life of SLBP; a major player in histone biosynthesis

Mark Kennedy 1*, Natasha Kovaleva2 

1Department of Computer Science,

Suleyman Demirel University, Kaskelen, Kazakhstan, 040900

2Department of Molecular Biology and Medical Genetics,

Kazakh National Medicine University named after Asfendiyarov, Almaty, 035000

*Presenting author

e-mails: [email protected], [email protected]

Eukaryotic cells need to achieve very delicate balance between DNA synthesis and histone levels and ensure the synthesis of histone proteins just during the S phase where the DNA is being replicated. Restriction of histone biosynthesis to S phase is critical for maintenance of genomic stability and proper gene regulation. Many transcriptional and posttranscriptional factors contribute coordinately to regulate expression of histone proteins, including transcription of histone genes, efficiency of pre-mRNA processing (the percentage of mature mRNA that reach to cytoplasm), change in mRNA half- life and degradation of excess histone proteins. Stem-Loop Binding Protein (SLBP), which binds to 3’ ends of histone mRNAs, is a key factor in histone biosynthesis. SLBP expression is cell cycle regulated without significant change in its mRNA level and this regulation is responsible for occurrence of bulk histone production during S phase. SLBP level is high during S phase and low in M  and G1 phase until next S phase. It has been found that SLBP is degraded at the end of S phase due on double phosphorylation triggered by CyclinA/CDK2 and similarly in G1, the SLBP stability seems to be low. SLBP protein, which is not degraded at the end of S phase was found to be toxic for cells and effects the rate of DNA replication. These findings show that S phase limited expression of SLBP is very critical for histone mRNA biosynthesis.


Keywords: Stem Loop Binding Protein (SLBP), histone mRNA, cell cycle, protein degradation, histone mRNA processing.